News about the Innovation Law and Tech Program or news about faculty or students that relates to law and technology
Pulse oximeters are known to be less accurate for patients with darker skin, but manufacturers have not changed their design or included a warning label disclosing this information. A recent settlement and guidance from the FDA could prompt changes in the market, however. In a new paper published in JAMA, Professor Sara Gerke and her […]
Colossal Biosciences is making headlines with its bold initiative to bring back the woolly mammoth, but the venture raises significant ethical and legal questions. Professor Jacob Sherkow is quoted in a new article from the MIT Technology Review about the complexities surrounding intellectual property in de-extinction efforts. He notes that while natural animals cannot be […]
The bankruptcy of the genetic testing company 23andMe has raised a number of issues, but one specifically prudent issue is the lack of legislation preventing the sale of customers’ data due to financial exigencies. Speaking with the Illinois News Bureau, Professor Sara Gerke explained why this issue is significant. “Companies like 23andMe are sitting on […]
Professor Sara Gerke was co-organizer of the Life Sciences AI Summit – Europe, which took place March 25–26, 2025, in Brussels, Belgium. The conference covered the ways in which artificial intelligence in the life sciences is affecting topics such as drug discovery and development as well as improving patient outcomes. Another important aspect of the […]
Professor Paul Heald delivered a lecture on Recent Empirical Research in Intellectual Property Law at the University of Glasgow on March 17. Part of their CREATe series of public lectures, Professor Heald discussed successes and failures in recent research projects and highlighted advances in methodology made by various researchers in empirical approaches to copyright, patent, trademark, […]
If 23andMe goes bankrupt, what happens to their millions of customers’ personal and genetic data? Sara Gerke, Melissa B. Jacoby, and I. Glenn Cohen explore this issue in a new article published on March 2 in the New England Journal of Medicine, titled “Bankruptcy, Genetic Information, and Privacy — Selling Personal Information.” The data are […]
A drug label is a vital piece of information in patent cases, but a series of recent decisions from the U.S. Court of Appeals for the Federal Circuit have changed how the court assesses claims. In a forthcoming article in the Stanford Law Review, Professor Jacob Sherkow calls this new confusion over labels “infringement by […]
Association for Molecular Pathology v. Myriad Genetics, Inc. was a cultural phenomenon when the Supreme Court’s ruling was issued, with the outcome taking a place on the front-page of most major newspapers in the United States. Reflecting more than 10 years on from the decision, however, Professor Jacob Sherkow tells the Carl R. Woese Institute […]
Self-treatment is a risky and controversial choice, as detailed in a new Nature article about a cancer researcher who decided to do research and treat her own breast cancer. In the article, Professor Jacob Sherkow is quoted about the dangers of publishing this kind of work; his comments are also included in a story for […]
In this episode, our newest faculty members, Bill Watson and Sara Gerke, sit down to discuss their path to Illinois Law, their specialties, and how they are enjoying their time at the College of Law thus far. Listen online.Listen on Apple Podcasts.Listen on Spotify Podcasts.Listen on Amazon Music.Listen on Pandora. If you have comments or […]